The 22q11 deletion syndrome (22q11DS) is characterized by abnormal development of the pharyngeal apparatus. Mouse genetic studies have identified Tbx1 as a key gene in the etiology of the syndrome, in part, via interaction with the fibroblast growth factor (Fgf) genes. Three murine Fgfs, Fgf3, Fgf8 and Fgf10 are coexpressed in different combinations with Tbx1. They are all strongly downregulated in Tbx12/2 embryos, implicating epistatic interactions. Supporting this, Tbx1 and Fgf8 have been shown to genetically interact in the development of the fourth pharyngeal arch artery (PAA) and Fgf10 was identified to be a direct downstream target of Tbx1. To dissect the epistatic relationships of these genes during embryonic development and the molecular pathogenesis of the Tbx1 mutant phenotype, we generated Fgf101/2; Tbx11/2 and Fgf32/2; Tbx11/2 mice. Despite strong hypotheses that Fgf10 is the key gene downstream of Tbx1 in the development of the anterior heart field, we do not find evidence for genetic interaction between Tbx1 and Fgf10. Also, the Fgf32/2; Tbx11/2 mutant mice do not show an additive phenotype. Furthermore, more severe defects do not occur in Fgf81/2; Tbx11/2 mutants by crossing in the Fgf3 null allele. There is a possible additive effect only in PAA remodeling in the Fgf101/2; Tbx11/2; Fgf81/2 embryos. Our findings underscore the importance of potential functional redundancy with additional Fgfs in the development of the pharyngeal apparatus and cardiovascular system via Tbx1. This redundancy should be considered when looking at individual FGF genes as modifiers of 22q11DS.
INTRODUCTION
The 22q11.2 deletion syndrome (22q11DS) [velo-cardiofacial syndrome (1) and DiGeorge syndrome (2) MIM 192430/ 188400], with an incidence of 1:4000 (3) is the most common microdeletion disorder in humans. It is associated with 1.5-3 Mb hemizygous 22q11.2 deletions and is characterized by multiple developmental anomalies, including cardiovascular [outflow tract (OFT) and aortic arch], ear, craniofacial (cleft palate, velo-pharyngeal insufficiency), thymic and parathyroid defects (4) .
Mouse genetic studies (5 -7) and mutational analysis in patients (8) have identified Tbx1, a gene on the deleted segment, as a key gene in the etiology of the syndrome. Tbx1 belongs to the T-box family of transcription factors, members of which have been shown to be important regulators of a number of tissues in development (8) . Tbx1 null mutant mice show perinatal lethality and have defects in most of # The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org the structures affected in 22q11DS patients, including cardiovascular and craniofacial anomalies (7) .
The pharyngeal apparatus is a transient vertebrate-specific embryonic structure, located lateral to the developing head, and is derived from all the three germ layers and the neural crest (9) . The structures primarily affected in 22q11DS are derived from the pharyngeal apparatus, suggesting that abnormal development of this structure causes most features of this disease (10) . Tbx1 is expressed in the pharyngeal pouch endoderm (PE), core and splanchnic mesoderm and transiently in the ectoderm (11 -13) .
The fibroblast growth factor (FGF) family of signaling molecules plays important roles in embryonic development by regulating cell proliferation, differentiation and migration (14) . The Fgfs comprise a 22-member gene family encoding secreted proteins that signal through a family of tyrosine kinase receptors (FGFRs) which are encoded by only four genes. A variety of Fgf ligands [Fgf3 (15) , Fgf4 (16), Fgf8 (17), Fgf10 (18), Fgf15 (19) and Fgf16 (20) ] and receptors [Fgfr1 (20) , Fgfr2 (20, 21) and Fgfr3 (21) ] are expressed in the developing pharyngeal apparatus.
In diverse organisms, Fgf signaling has been shown to genetically interact with the function of a number of T-box genes in development. Xenopus Brachyury (Xbra), a member of the T-box gene family, has been shown to directly activate expression of eFGF (22) . Also, Xbra and eFGF are components of an indirect autoregulatory loop in which each maintains expression of the other (22, 23) . The gene, fgf8, genetically interacts with ntl and spt, two zebrafish T-box transcription factors in the development of the posterior mesoderm (24) . Zebrafish tbx5 regulates fgf10, which in turn maintains tbx5 expression during limb outgrowth (25) . Also, Tbx5 is upstream of Fgf signaling in limb bud development in mouse (26) . Importantly, Fgf8 and Tbx1 genetically interact in the development of the fourth pharyngeal arch artery (PAA) (17) .
The core mesoderm of the pharyngeal arches, derived from the paraxial mesoderm, forms the craniofacial muscles (27) and participates in the development of the PAAs (9) . A subset of the pharyngeal mesoderm cells, termed the anterior heart field (AHF), has been shown to be important for the development of the cardiac OFT and the right ventricle (18,28 -30) . Tbx1 and Fgf10 are coexpressed in the AHF (17) . Also, Fgf10 expression is lost in the AHF in the Tbx12/2 embryos (17). This suggests that Fgf10 may act downstream of Tbx1. In fact, Fgf10 has been shown to be a direct downstream target of Tbx1 in an in vitro cell culture system (12) .
The endoderm of the pharyngeal apparatus gives rise to the thymus, parathyroid and part of the thyroid; organs which are frequently affected in 22q11DS. Tbx1 and another Fgf, Fgf3, are coexpressed, in the pharyngeal PE (15, 17, 31) , and Fgf3 is downregulated in the PE of the Tbx12/2 embryos (32, 33) .
In view of these findings, we hypothesized that dosage reduction of either Fgf10 or Fgf3 would enhance the Tbx1 haploinsufficiency phenotype. We therefore generated Fgf10þ/2; Tbx1þ/2 and Fgf32/2; Tbx1þ/2 mice. Surprisingly, Fgf10þ/2; Tbx1þ/2 and the Fgf32/2; Tbx1þ/2 mutant mice do not show any additive phenotype.
Fgf8, besides Fgf10, is expressed in the AHF (18) . It may thus serve redundant functions with Fgf10 in this tissue.
Fgf8, along with Fgf3, is expressed in the PE (17) . As only about half of the Fgf8þ/2; Tbx1þ/2 embryos present with aortic arch artery remodeling defects (17), we hypothesized that Fgf3 and Fgf8 may cooperate in the development of the PE. We thus generated Fgf10þ/2; Tbx1þ/2; Fgf8þ/2 and Fgf32/2; Tbx1þ/2; Fgf8þ/2 mice. We show that more severe defects do not occur in Fgf8þ/2; Tbx1þ/2 mutants by crossing in the Fgf3 null allele. There is a possible additive effect only in PAA remodeling in the Fgf10þ/2; Tbx1þ/2; Fgf8þ/2 embryos. Our findings underscore the importance of potential functional redundancy with additional Fgfs in the development of the pharyngeal apparatus and cardiovascular system via Tbx1.
RESULTS

Expression of Tbx1, Fgf10, Fgf3 and Fgf8
To compare the patterns of expression of Tbx1, Fgf10, Fgf3 and Fgf8 in the developing mouse embryo, we performed whole-mount RNA in situ hybridization studies. At E9.5, Tbx1 is expressed in the pharyngeal PE ( Fig. 1B and I ), core mesoderm of the pharyngeal arches and posterior otic vesicle (Fig. 1B) . The endodermal expression domain of Tbx1 (Fig. 1I ) overlaps with that of Fgf3 ( Fig. 1C and H) and Fgf8 ( Fig. 1D and J) . Fgf10 is coexpressed with Tbx1 in the core mesoderm of the pharyngeal arches (Fig. 1A) . Interestingly, Tbx1 (Fig. 1F) , Fgf10 (Fig. 1E) and Fgf8 (Fig. 1G ) are all coexpressed in the AHF cells, a subset of the pharyngeal mesoderm, which are thought to migrate and contribute to the wall of the cardiac OFT and the right ventricle (18, 28, 29) .
Tbx1 mutant mice have been described previously and found to model many aspects of 22q11DS (5) . To determine whether the expression of these Fgfs is altered in Tbx1 mutants, we performed in situ hybridization of Tbx12/2 embryos at E9.5. In the Tbx12/2 embryos, Fgf3 (Fig. 2D ) (32, 33) and Fgf8 (17) expression in the pharyngeal endoderm (PE) is lost. The loss of expression is specific to these genes and not due to the lack of endodermal cells, as other endodermal markers such as Pax1 and Nkx2.5 are expressed in the endoderm of the null mutants (data not shown) (17) . Ectodermal expression of Fgf10 is intact in the first arch of the Tbx1 homozygous null embryos (Fig. 2B) . Diffuse Fgf10 expression is seen in the mesoderm of the first arch but is missing in the caudal arches of the Tbx1 homozygous null embryos (Fig. 2B) . Also, the AHF domain of expression of Fgf10 (Fig. 2B) and Fgf8 (34) is not detected in these mutants, whereas expression of Nkx2.5 and Isl1, also present in the AHF, is however conserved (data not shown) (17) . These results suggest that the Tbx1 function in OFT and pharyngeal pouch development, revealed by severe OFT and endoderm defects in the Tbx12/2 mutants, may be mediated by Fgf signaling in the AHF and the endoderm.
Generation of Fgf101/2; Tbx11/2 mice Our in situ hybridization results show that the expression of Fgf10, which overlaps with that of Tbx1, is diminished in the Tbx1 null mutant mice in the core mesoderm and the AHF. Tbx12/2 mutants have missing and abnormal craniofacial muscles (35, 36) and have a single cardiac OFT (5, 7) . Fgf10 has been shown to be a direct downstream target of Tbx1 in an in vitro cell culture system (12) . Also, it has been proposed that Fgf10 may be the mediator of the cell nonautonomous function of Tbx1 in regulating cell contribution to the OFT (12) . In view of these very important findings, we hypothesized that dosage reduction of Fgf10 would enhance the Tbx1 haploinsufficiency phenotype. We thus crossed the Tbx1þ/2 mice (5) with the Fgf10þ/2 mice (37) to generate Fgf10þ/2; Tbx1þ/2 mice.
Genotyping of the litters from these crosses at P10 shows Mendelian distribution of 25% of Fgf10þ/2, Tbx1þ/2, wildtype (WT) and double heterozygous mice (Table 1) . These proportions are in accordance with genes mapping to different chromosomes following an independent allelic segregation. Also, the presence of 25% double heterozygous mice demonstrates that double heterozygosity does not cause embryonic or perinatal lethality. External analysis of newborn double heterozygous pups did not reveal any significant abnormality. There was no difference in size observed between the double heterozygous and the WT pups, thus showing the absence of major growth defects.
Craniofacial malformations
The mesodermal core of the first pharyngeal arch gives rise to the muscles of mastication (38) . Tbx1 (Fig. 1B) and Fgf10 (Fig. 1A) are coexpressed in this region at E9.5 and Fgf10 is more diffusely expressed in the first arch core of the Tbx1 null mutants (Fig. 2B ) compared with WT embryos ( Fig. 2A) . The muscles of mastication are largely missing in the Tbx12/2 embryos (35, 36) . Also, an Fgf10 enhancer-trap nlacz transgene fails to be expressed in the proximal core region of the first arch in the same mouse model (36) . We were interested in evaluating whether Tbx1 and Fgf10 co-operate in the development of the muscles of the first arch. Since the Fgf10þ/2; Tbx1þ/2 double heterozygous mice survived in normal Mendelian ratios, we suspected that the muscles of mastication would be normal. To more carefully examine these muscles, we performed a detailed histological analysis of these muscles (temporalis, pterygoids and masseter) in the Fgf10þ/2; Tbx1þ/2 double heterozygous embryos (n ¼ 5). All the muscles were present and appeared anatomically normal (Fig. 3A -C) . It was found that most 22q11DS patients have palatal malformations and 10% have an overt cleft palate (39, 40) . Both the Tbx1 and the Fgf10 null mutants have a cleft palate (35, 41) . Thus, we analyzed the double heterozygous mice for cleft palate. The palate was normal in all the embryos examined (n ¼ 5) (Fig. 3D ). This indicates that if any genetic interactions between Tbx1 and Fgf10 exist in craniofacial muscle or palate development, they are not disrupted by reducing the gene dosage of each gene by half. It is possible that further reduction in dosage will be necessary to elicit a phenotype.
Thyroid and thymus anomalies
The phenotypic spectrum of 22q11DS may occasionally include hypothyroidism (40) . The thyroid gland is missing in the Fgf10 null mutants (42) and the Tbx1 null mutants have a single lobed thyroid gland (35) . Evaluation of the Fgf10þ/2; Tbx1þ/2 mice did not reveal any thyroid anomalies (n ¼ 5) (Fig. 3E ). Immune deficiencies are seen in a major subset of 22q11DS patients (40) . This has been associated with hypoplasia or aplasia of the thymus gland. In fact, thymus gland aplasia was one of the hallmark features described in the first report of the syndrome (2). Tbx12/2 mice have thymus gland aplasia (7) and the Fgf102/2 mice have a hypoplastic thymus (42) , raising the question if the two genes interact in thymic development. Analysis of the double heterozygous mice revealed a normally located thymus, which was appropriate in size (n ¼ 5) (Fig. 3F) . This demonstrates that reduction of dosage of both Tbx1 and Fgf10 by half does not disrupt development of the thyroid and the thymus. As stated earlier, it is possible that further reduction in dosage may be necessary to observe a developmental defect.
Analysis of the cardiovascular system in Fgf101/2; Tbx11/2 embryos Cardiovascular defects, arising from the abnormal development of the OFT and the PAAs, occur in 60-75% of 22q11DS patients (39, 40) . The AHF is a source of cells to lengthen the outflow end of the developing heart (18, 28, 29) . Elongation of the OFT is necessary for wedging, which is responsible for the correct alignment of the aorta and the pulmonary trunk with the left and the right ventricles, respectively. Failure of this process leads to congenital heart malformations such as tetralogy of Fallot (TOF) and double outlet right ventricle (DORV) (43) .
The distal OFT is hypoplastic in the Tbx1 homozygous mutant embryos (31) , suggesting an important role of Tbx1 in regulating addition of cells from the AHF to the developing heart (44) . Given the loss of AHF expression of Fgf10 in the Tbx12/2 mice, we postulated that this role of Tbx1 may be mediated by Fgf10. We thus investigated whether OFT development was impaired in the Fgf10þ/2; Tbx1þ/2 mice.
We thus analyzed the phenotype of the Fgf10þ/2; Tbx1þ/2 embryos at E17.5 (n ¼ 7) by standard histological techniques. All the embryos examined showed normal morphology of the heart and correct alignment of the aorta and the pulmonary trunk with the ventricles (Fig. 4A and B) . The double heterozygous embryos did not show any alignment anomalies such as TOF or DORV. We additionally analyzed the double heterozygous embryos at E11.5 for OFT hypoplasia. Overall, the morphology of the heart chambers and the OFT region was normal in the Fgf10þ/2: Tbx1þ/2 embryos (n ¼ 3) (Fig. 4C and D) .
The core mesodermal cells of the pharyngeal arches contribute to the development of the PAAs (9); Tbx1 and Fgf10 are coexpressed in the mesoderm. We thus examined the double heterozygous embryos for remodeling defects of the PAAs. None of the seven embryos examined had any aortic Table 1 . Mendelian ratio analysis at P10 of litters from Fgf10þ/2 Â Tbx1þ/2 and Fgf3þ/2; Tbx1þ/2 Â Fgf3þ/2; Tbx1 þ/þ matings arch artery anomalies such as interrupted aortic arch (IAA), right aortic arch (RAA) or aberrant origin of the right subclavian artery (ARSA) (Fig. 4E -G) . We thus did not observe any defects in the cardiovascular system of the Fgf10þ/2; Tbx1þ/2 embryos when compared with the WT (n ¼ 6), Tbx1þ/2 (n ¼ 4) and the Fgf10þ/2 embryos (n ¼ 5).
Fgf8 is coexpressed with Fgf10 in the AHF
Even though in situ expression analysis (Fig. 2B ) and in vitro cell culture data (12) suggested that Fgf10 may be downstream of Tbx1 in the AHF; surprisingly, the Fgf10þ/2; Tbx1þ/2 mice did not have any cardiovascular anomalies. This led us to hypothesize that other Fgfs in the AHF may compensate for the reduction of Fgf10 gene dosage. Also, the Fgf10 null mutants do not have any OFT alignment defects (37, 45, 46) , suggesting that it is not the only Fgf ligand involved in the development of this tissue.
In situ hybridization of WT embryos shows that Fgf8 (Fig. 1G) is coexpressed with Fgf10 (Fig. 1E) in the AHF at E9.5 (18) . Fgf8 hypomorphs have cardiovascular anomalies including OFT septation, rotation and alignment defects (47, 48) , reminiscent of the defects seen in 22q11DS. Cremediated excision of an Fgf8 conditional allele in the Tbx1 expression domain gives rise to cardiovascular defects involving the OFT and proximal great vessels (49) . Inactivation of Fgf8 in the AHF leads to OFT rotation/alignment defects (50), whereas ablation of Fgf8 in the pharyngeal ectoderm or ectoderm and endoderm causes aortic arch interruptions and not OFT defects (51) . These results suggest that Fgf8 is required in the AHF for normal development of the OFT. We thus speculated that Fgf8 may compensate for the loss of Fgf10 in the AHF. Intact Fgf8 -Tbx1 interaction in the AHF may be responsible for normal cardiovascular development in the Fgf10þ/2; Tbx1þ/2 mice. We checked what could be the consequence of applying a dosage reduction of Fgf8 in the Fgf10þ/2; Tbx1þ/2 mice with regard to the development of the OFT. We thus crossed the Fgf10þ/2; Tbx1þ/2 mice with the Fgf8þ/2 mice (52) to generate Fgf10þ/2; Tbx1þ/2; Fgf8þ/2 mice.
Phenotypic analysis of Fgf101/2; Tbx11/2; Fgf81/2 mice In order to evaluate the triple heterozygous embryos for cardiovascular defects, we performed a histological analysis at E17.5 (n ¼ 6). Analysis of the triple heterozygous embryos did not reveal any cardiac defects. The aorta and the pulmonary trunk were correctly aligned with the left and right ventricles, respectively. Alignment defects such as TOF or DORV were not seen in these mutants. This supports the idea that if any genetic interactions between Tbx1, Fgf8 and Fgf10 exist, they are not disrupted by reducing the gene dosage of each gene by half.
Tbx1 is required for the fourth PAA formation and growth. Hypoplastic fourth PAA is seen in 100% of the Tbx1þ/2 embryos at E10.5 (17) . At term, depending on the genetic background, 3-27% of the mutants have fourth PAA-derived defects such as interrupted aortic arch-type B (IAA-B), RAA and ARSA (17, 35) . None of the Tbx1þ/2 mutants, in this study (in a C57BL/6 Â FVB Â CD1 background) (n ¼ 5), showed aortic arch artery remodeling defects. Vascular anomalies such as ARSA (34%), RAA (17%) and IAA-B (17%) were seen in the triple heterozygous mutants (n ¼ 6) ( Table 2) (Fig. 5B and  C) . The right subclavian artery arose from the aortic arch or from the descending aorta instead of the brachiocephalic trunk, in the mutants that had ARSA. We found that 17% of the Fgf8þ/2; Tbx1þ/2 embryos had ARSA (n ¼ 6) ( Table 2) . Aortic arch remodeling defects described earlier were not seen in Fgf10þ/2; Fgf8þ/2 embryos (n ¼ 5) as well as Fgf10þ/2; Tbx1þ/2 embryos (n ¼ 7). This suggests that there is a possible genetic interaction between Tbx1, Fgf8 and Fgf10 in the development of the fourth PAA.
Generation of Fgf32/2; Tbx11/2 mice Tbx1 (Fig. 1I) and Fgf3 (Fig. 1H) are coexpressed in the PE at E9.5. Also, Fgf3 (Fig. 2D) (32, 33) and Fgf8 (17) expression are lost in the PE of the Tbx12/2 embryos. We hypothesized that Fgf3, besides Fgf8 (17), is another signaling molecule downstream of Tbx1 in the PE. We speculated that loss of Fgf3 would enhance the Tbx1 haploinsufficiency phenotype. To test this hypothesis, we crossed the Tbx1þ/2 mice (5) with the Fgf32/2 mice (53); in F1 generation, we then crossed Tbx1þ/2; Fgf3þ/2 mice with Tbx1þ/þ; Fgf3þ/2 mice to obtain Fgf32/2; Tbx1þ/2 mice. Genotyping of the F2 animals at P10 shows that mice of most of the genotypes are present in normal Mendelian ratios. Those not present in normal Mendelian ratios were the Fgf32/2 mice and Fgf32/2; Tbx1þ/2 mice, which constituted 8.4 and 3.9% Table 2 . Defects in E17.5 embryos (25) 1 (25) ARSA, aberrant origin of right subclavian artery; CxlAA, cervical aortic arch. respectively, instead of the expected 12.5%, of the 178 pups genotyped (Table 1 ). Reduced viability of Fgf32/2 newborns has been reported before but defects that could result in lethality have not been described (54) .
Phenotypic analysis of Fgf32/2 mice
Because of their decreased viability, Fgf32/2 embryos at E17.5 were histologically analyzed for possible developmental defects. After detailed histological analysis, it has not been possible to identify a specific cause of neonatal death for these mutants. Fgf32/2 embryos are present in the normal Mendelian ratios at E17.5 (data not shown), demonstrating that they survive embryogenesis. However, Fgf32/2 animals often appeared immature compared with their littermates and this may have compromised their survival. Interestingly, two of the three (67%) Fgf32/2 embryos examined at E17.5 had hypoplastic thymus glands (Fig. 6B ) ( Table 2 ), but this cannot account for neonatal lethality.
Phenotypic analysis of Fgf32/2; Tbx11/2 mice
Most of the physical malformations in 22q11DS arise from abnormal development of the pharyngeal apparatus. Fgf3 is lost in the PE of the Tbx1 null mutants (Fig. 2D) . We thus analyzed the Fgf32/2; Tbx1þ/2 embryos at E17.5 for defects arising from the pharyngeal apparatus. Histological analysis (n ¼ 10) revealed that seven embryos (70%) had hypoplastic thymus and two embryos (20%) had ARSA (Fig. 6C) . About 10-27% (17,35) of the Tbx1þ/2 mice have abnormalities in the patterning of the aortic arch arteries but none of them have hypoplastic thymus (35) . A total of 67% of the Fgf32/2 embryos have hypoplastic thymus (Table 2) . We did not observe PAA or thymic defects in the Fgf3þ/2; Tbx1þ/2 mice. These results suggest that Fgf32/2; Tbx1þ/2 animals do not present with higher penetrance of thymus or PAA remodeling defects when compared with Tbx1þ/2 or Fgf32/2 animals.
Fgf8 is coexpressed with Fgf3 in the endoderm
Even though the in situ expression analysis (Fig. 2D) suggested that Fgf3 may be downstream of Tbx1 in the PE; surprisingly, the Fgf32/2; Tbx1þ/2 mice did not have increased penetrance of defects seen either in Tbx1þ/2 or Fgf32/2 mice. This led us to speculate that other Fgfs expressed in the PE may compensate for the loss of Fgf3.
In situ hybridization of WT embryos at E9.5 shows that Fgf8 (Fig. 1J) is coexpressed with Fgf3 (Fig. 1H) in the PE. Fgf8 hypomorphs have remodeling defects of the PAAs including IAA-B and RAA (47, 48) , reminiscent of the defects seen in 22q11DS. Thymic and parathyroid aplasia and hypoplasia was also in the Fgf8 hypomorphs (47) . Also, Tbx1 and Fgf8 genetically interact in the development of the fourth PAA (17) . These results suggest that Fgf8 is required for normal development of the derivatives of the PE. We thus speculated that Fgf8 may compensate for the loss of Fgf3 in the PE. To test this possibility, we generated Fgf32/2; Tbx1þ/2; Fgf8þ/2 mice by crossing Fgf32/2; Tbx1þ/2 mice with Fgf3þ/2; Fgf8þ/2 mice.
Phenotypic analysis of Fgf32/2; Tbx11/2; Fgf81/2 mice
We assessed the triple mutant embryos (Fgf32/2; Tbx1þ/2; Fgf8þ/2) at E17.5 by the detailed histological analysis (n ¼ 4). Hypoplasia of the thymus was seen in three (75%) mutant embryos (Fig. 5E ). Aortic arch remodeling defects such as ARSA and IAA-B were also observed ( Fig. 5F ) ( Table 2 ) but were not increased in penetrance when compared with the Fgf8þ/2; Tbx1þ/2 embryos (17). These data suggest that other Fgfs may interact with Tbx1 in the development of the PE.
DISCUSSION
Genetic interaction between Tbx1 and Fgfs in the AHF
The AHF is a recently described population of pharyngeal mesodermal cells which forms the OFT and the right ventricle of the heart (18, 28, 29) . The OFT is affected in one-third of the patients with congenital heart defects (55). Thus, it is important to understand the genetics and signals regulating the development of the OFT. 22q11DS is one of the most common genetic causes of OFT defects. Cells of the murine AHF express Tbx1 (the key gene implicated in 22q11DS) and Fgf10. Decreased contribution of the AHF cells to the OFT myocardium is seen in Tbx1 homozygous null mutant embryos (12) . Also, targeted deletion of Tbx1 in the AHF causes a proliferation defect, which could explain the hypoplastic OFT seen in the null mice (12) .
In situ hybridization analysis of the Tbx1 homozygous null mutant embryos, which model 22q11DS, shows downregulation of Fgf10 in the AHF. Also, it has been shown using an in vitro cell culture system that Tbx1 can bind to the Fgf10 promoter and activate a luciferase reporter (12) . These results provided a compelling reason to test for an in vivo interaction between Tbx1 and Fgf10. Our results show that the Fgf10þ/2; Tbx1þ/2 double heterozygous mice do not have any cardiac defects and do not appear to interact genetically, on their own.
A number of Fgfs are expressed in several specific tissues during development but seem to have no functional significance in the same. Even though Fgf2 is expressed by endothelial cells and is angiogenic, it does not appear to be essential for the development of the vascular system (56) . Fgf3 is expressed in a variety of tissues during development, such as extraembryonic tissue, parietal endoderm, mesoderm in the primitive streak, hindbrain rhombomeres and the pharyngeal pouches. However, Fgf3 mice are viable as homozygotes and display a fully penetrant phenotype only with respect to the development of the tail (53, 54) . Similarly, although Fgf10 transcripts are present in many diverse tissues during development, including the AHF, Fgf10 null mutants do not have any OFT defects (37, 45, 46) . Loss of Fgf10 causes defects at sites where it cannot be compensated by other Fgf genes. These developmental defects provide evidence that Fgf ligands can functionally compensate for the absence of Fgf normally expressed in the same tissue.
As Fgf8 has a similar expression pattern to Fgf10 in the AHF, we hypothesized that the two may act redundantly in the development of the OFT. We thus generated Fgf10þ/2; Tbx1þ/2; Fgf8þ/2 triple heterozygous mice. Surprisingly, these embryos do not have any cardiac defects. We believe that this could be due to the following reasons.
AHF development occurs normally in Fgf8 null heterozygotes (Fgf8þ/2) but is disrupted at lower levels of Fgf8 that occur in Fgf8 hypomorphs (47, 48) ; tissue-specific deletion of Fgf8 in the Tbx1 expressing domain or in the AHF (50) results in cardiac OFT defects (49) , revealing the extreme sensitivity of the AHF to Fgf8 levels. Thus, it is possible that there is sufficient Fgf8 mRNA and protein in the Fgf10þ/2; Tbx1þ/2; Fgf8þ/2 triple heterozygous mice for normal development of the OFT.
Dosage sensitivity to Fgf8 is seen in the development of various organs including the salivary gland (57), cardiovascular system (47, 48) and the telencephalon (58) . These data support the hypothesis that the correct levels of Fgf8 are needed for normal development of numerous organs.
In addition to Fgf8 and Fgf10, Fgf15 is expressed in the murine AHF (19) . Fgf15 homozygous null mutant embryos display cardiovascular anomalies primarily affecting the OFT, including alignment defects of the great vessels, overriding aorta and DORV (19) . Fgf15þ/2; Tbx1þ/2 compound heterozygous mice show no significant increase in the penetrance or severity of cardiovascular anomalies relative to either Tbx1þ/2 or Fgf15þ/2 mice (19) . Consistent with these data, it is tempting to speculate that Fgf15 may also be redundant with Fgf8 and Fgf10 in the AHF.
Further evidence for our hypothesis comes from the analysis of heart defects in the Fgfr2-IIIb mutant mice (46) . Fgfr2-IIIb is the major receptor for Fgf10. Most of the Fgfr2-IIIb mutant mice have OFT alignment anomalies such as overriding aorta and DORV (46) . However, formation and alignment of the OFT are normal in the Fgf10 mutant mice. Thus, other Fgfs which act via Fgfr2-IIIb (Fgf3, Fgf7 and Fgf15) could be redundant with Fgf10 in the AHF.
An alternative explanation for our results is that Tbx1 and Fgfs do not interact in the AHF. This hypothesis is supported by the fact that the Fgf8þ/2; Tbx1þ/2 (17), Fgf15þ/2; Tbx1þ/2 (19), Fgf10þ/2; Tbx1þ/2 and the Fgf10þ/2; Tbx1þ/2; Fgf8þ/2 (this report) embryos do not have AHF-related cardiovascular defects. Also, by driving Fgf8 expression in Tbx1 positive cells, it has been suggested that the function of Tbx1 in the AHF development is not mediated by Fgf8 (59) . Conditional deletion of Fgfrs in the AHF in a Tbx1 mutant background will conclusively reveal genetic interaction between Tbx1 and the Fgf signaling pathway in the AHF.
Genetic interaction between Tbx1 and Fgfs in the pharyngeal PE
Defects in the thymus and parathyroid contribute to the morbidity of 22q11DS in the form of immunodeficiency and hypocalcemia, respectively (40) . These glands are derivatives of the PE. Inactivation of Tbx1 in the PE results in 22q11DS malformations (33) . However, the genetic pathways and signaling molecules downstream of Tbx1 in the PE are not known.
The fgf3 gene has been shown to play a role in the zebrafish pharyngeal arch development (60, 61) . Fgf3 null mutant mice have been generated and defects in the development of the tail and inner ear have been described in these mutants (53, 54) . We show that 67% of the Fgf3 null mutants have a hypoplastic thymus. This is the first report to our knowledge describing PE-derived defects in these mutants.
Our results show that the PE domain of expression of Fgf3 is missing in the Tbx1 null mutants at E9.5. We had speculated that dosage reduction of Fgf3 would enhance the Tbx1 haploinsufficiency phenotype. Unexpectedly, the Fgf32/2; Tbx1þ/2 mutant mice show no significant increase in the penetrance or severity of PE-derived defects relative to the Tbx1þ/2 or the Fgf32/2 mice alone.
Since Fgf8 is coexpressed with Fgf3 in the PE, we hypothesized that Fgf8 compensates for the lack of Fgf3 in the pharyngeal pouch. We thus generated Fgf32/2, Tbx1þ/2; Fgf8þ/2 mice. These mice too do not have increased penetrance or severity of either thymic or aortic arch artery remodeling defects when compared with Fgf32/2, Tbx1þ/2 (5) or Fgf8þ/2; Tbx1þ/2 (17) mice.
Fgf4 (16) and Fgf16 (20) are also expressed in the PE. A role for Fgf4 in the PE has yet to be established as the Fgf4 mutants are early embryonic lethal (62) . The function of Fgf16 in the PE is yet to be described. It is thus possible that Fgf4 and/ or Fgf16 is functionally redundant with Fgf3 and Fgf8 in the PE.
A high degree of redundancy in Fgf signaling has been established during development. Simultaneous depletion of both FGF3 and FGF8 by injection of fgf3 and fgf8 morpholinos into WT zebrafish embryos or injection of fgf3 morpholinos into ace (Fgf8) mutants blocks otic vesicle formation in most treated embryos, indicating that these two FGFs have redundant roles in zebrafish otic placode induction (63 -65) . Mice double mutant for Fgf3 and Fgf10 have otic vesicles that are severely reduced in size, showing redundant roles of these Fgfs, acting in combination as neural signals for otic vesicle formation (53) . In addition, fgf8 and fgf3 have redundant essential functions in pharyngeal cartilage development in zebrafish (66) .
On the basis of this established functional redundancy in Fgf signaling in development, we propose that a number of Fgfs could be downstream of Tbx1 in the development of both the AHF and the PE. Conditional deletion of the AHF or endoderm-expressed Fgfs in the Tbx1 null background will reveal whether Fgf signaling is downstream of Tbx1 in the development of these structures.
Overall, our findings underscore the importance of functional redundancy of Fgfs in the development of the pharyngeal apparatus and the cardiovascular system via Tbx1. This redundancy should be considered when looking at individual FGFs as modifiers of 22q11DS.
MATERIALS AND METHODS
Mouse strains and genotyping
Tbx1þ/2 (5), Fgf10þ/2 (37), Fgf8þ/2 (52) and Fgf32/2 (53) mice have been previously described. Genotyping was performed with the following PCR primer pairs: Tbx1 (35), Fgf3 (53) and Fgf8 (52) as previously described; Fgf10 mutant allele (Fgf10-F, 5 0 -CTT CCA GTA TGT TCC TTC TG-3 0 ; Fgf10-R, 5 0 -TGC TGT CCA TCT GCA CGA GA 3-0 ).
Histology
Mouse embryos were isolated in PBS and fixed in 10% neutral-buffered formalin (Sigma) overnight. Following fixation, the embryos were dehydrated through a graded ethanol series and then embedded in paraffin and sectioned at 7 -10 mm. All sections were stained with hematoxylin and eosin using standard protocols. Serial sections were examined and representative sections are shown here.
Whole-mount in situ hybridization
Digoxigenin-labeled complementary RNA probes to mouse Tbx1 (13), Fgf8 (67), Fgf3 (32) and Fgf10 (41) were prepared by the standard methods. Whole-mount in situ hybridization was performed as previously described (32, 68) . Embryos were photographed, post-fixed in 4% PFA, dehydrated through a graded ethanol series, embedded in paraffin and sectioned at 10 mm.
